Literature DB >> 11337355

FE65 in Alzheimer's disease: neuronal distribution and association with neurofibrillary tangles.

B Delatour1, L Mercken, K H El Hachimi, M A Colle, L Pradier, C Duyckaerts.   

Abstract

FE65, a protein expressed in the nervous system, has the ability to bind the C-terminal domain of the amyloid precursor protein. This suggests a role for FE65 in the pathogenesis of Alzheimer's disease (AD). The present study was conducted to find out if the distribution of FE65 immunoreactivity was affected during the course of AD, and to determine the degree of co-localization of FE65 with other proteins known to be involved in AD. Single immunoperoxidase-labeling experiments, conducted on six sporadic AD patients and six nondemented age-matched controls, showed that the proportion of volume occupied by FE65 immunoreactivity was not modified in the isocortex of AD patients. However, in hippocampal area CA4, increased FE65 immunoreactivity seemed to be associated with the severity of the disease. Double-immunofluorescent labeling did not show any clear co-localization of FE65 with the amyloid precursor protein. FE65 immunoreactivity was also absent from focal and diffuse deposits of the beta-amyloid peptide. Unexpectedly double labeling experiments showed a co-localization of FE65 and tau proteins in intracellular tangles. Ultrastructural observations confirmed that FE65 was associated with paired helical filaments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337355      PMCID: PMC1891962          DOI: 10.1016/S0002-9440(10)64113-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients.

Authors:  S Y Guénette; L Bertram; A Crystal; B Bakondi; B T Hyman; G W Rebeck; R E Tanzi; D Blacker
Journal:  Neurosci Lett       Date:  2000-12-15       Impact factor: 3.046

2.  AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease.

Authors:  V Buée-Scherrer; O Condamines; C Mourton-Gilles; R Jakes; M Goedert; B Pau; A Delacourte
Journal:  Brain Res Mol Brain Res       Date:  1996-07

3.  The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system.

Authors:  D M McLoughlin; C C Miller
Journal:  FEBS Lett       Date:  1996-11-18       Impact factor: 4.124

4.  cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein.

Authors:  S L Bressler; M D Gray; B L Sopher; Q Hu; M G Hearn; D G Pham; M B Dinulos; K Fukuchi; S S Sisodia; M A Miller; C M Disteche; G M Martin
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

5.  Expression of the neuron-specific FE65 gene marks the development of embryo ganglionic derivatives.

Authors:  A Simeone; A Duilio; F Fiore; D Acampora; C De Felice; R Faraonio; F Paolocci; F Cimino; T Russo
Journal:  Dev Neurosci       Date:  1994       Impact factor: 2.984

6.  Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics.

Authors:  F B Gertler; K Niebuhr; M Reinhard; J Wehland; P Soriano
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

7.  Characterization of sorting signals in the beta-amyloid precursor protein cytoplasmic domain.

Authors:  A Lai; S S Sisodia; I S Trowbridge
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

8.  Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type.

Authors:  C Duyckaerts; J J Hauw; F Bastenaire; F Piette; C Poulain; V Rainsard; F Javoy-Agid; P Berthaux
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.

Authors:  S Y Guénette; J Chen; P D Jondro; R E Tanzi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein.

Authors:  F Fiore; N Zambrano; G Minopoli; V Donini; A Duilio; T Russo
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

View more
  8 in total

1.  Real-time PCR quantitation of FE65 a beta-amyloid precursor protein-binding protein after traumatic brain injury in rats.

Authors:  Morio Iino; Masato Nakatome; Yoshiaki Ogura; Harutoshi Fujimura; Hisanaga Kuroki; Hiromasa Inoue; Yukiko Ino; Tasuku Fujii; Toshiyuki Terao; Ryoji Matoba
Journal:  Int J Legal Med       Date:  2003-04-18       Impact factor: 2.686

2.  Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition.

Authors:  Maggie Roy; Cécile Cardoso; Olène Dorieux; Carole Malgorn; Stéphane Epelbaum; Fanny Petit; Audrey Kraska; Emmanuel Brouillet; Benoît Delatour; Martine Perret; Fabienne Aujard; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2014-07-18       Impact factor: 4.673

3.  Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis.

Authors:  Sangdeuk Ha; Ruth Furukawa; Marcus Fechheimer
Journal:  Neurobiol Aging       Date:  2010-02-04       Impact factor: 4.673

4.  Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy.

Authors:  Elizabeth A Grace; Jorge Busciglio
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 5.  Cytoplasmic tail adaptors of Alzheimer's amyloid-beta protein precursor.

Authors:  Masaoki Kawasumi; Shuji Matsuda; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

Review 6.  The Yin and Yang of YY1 in the nervous system.

Authors:  Ye He; Patrizia Casaccia-Bonnefil
Journal:  J Neurochem       Date:  2008-05-15       Impact factor: 5.372

Review 7.  Signal transduction therapeutics: relevance for Alzheimer's disease.

Authors:  Odete A B da Cruz e Silva; Margarida Fardilha; Ana Gabriela Henriques; Sandra Rebelo; Sandra Vieira; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Total body 100-mGy X-irradiation does not induce Alzheimer's disease-like pathogenesis or memory impairment in mice.

Authors:  Bing Wang; Kaoru Tanaka; Bin Ji; Maiko Ono; Yaqun Fang; Yasuharu Ninomiya; Kouichi Maruyama; Nakako Izumi-Nakajima; Nasrin Begum; Makoto Higuchi; Akira Fujimori; Yoshihiko Uehara; Tetsuo Nakajima; Tetsuya Suhara; Tetsuya Ono; Mitsuru Nenoi
Journal:  J Radiat Res       Date:  2013-08-01       Impact factor: 2.724

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.